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ABSTRACT 
Aims: The relationship between educational level and the risk of all-cause mortality is well 
established, whereas the association with vascular events in individuals with type 2 diabetes is 
not well described. Any association may reflect a link with common cardiovascular or lifestyle-
based risk factors. 
Methods: The relationships between the highest level of educational attainment and major 
cardiovascular events, microvascular complications and all-cause mortality were explored in a 
cohort of 11,140 individuals with type 2 diabetes. Completion of formal education before the age 
of 16 was categorized as a low level of education. Regional differences between Asia, East 
Europe and Established Market Economies were also assessed. 
Results: During a median of 5 years of follow up, 1,031 (9%) patients died, 1,147 (10%) 
experienced a major cardiovascular event and 1,136 (10%) a microvascular event. After 
adjustment for baseline characteristics and risk factors, individuals with lower education had an 
increased risk of cardiovascular events (hazard ratio (HR) 1.31, 95% CI 0.1.16–1.48, p<0.0001), 
microvascular events (HR 1.23, 95% CI 1.09–1.39, p=0.0013) and all-cause mortality (HR 1.34, 
95% CI 1.18–1.51, p<0.0001). In regional analyses the increased risk of studied outcomes 
associated with lower education was weakest in Established Market Economies and strongest in 
East Europe. 
Conclusions: A low level of education is associated with an increased risk of vascular events and 
death in patients with type 2 diabetes, independently of common lifestyle associated 
cardiovascular risk factors. The effect size varies between geographical regions.  
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1. Introduction 
Lower levels of educational attainment are associated with a higher incidence of type 2 diabetes 
mellitus, especially in high income countries [1, 2]. Although the prevalence of type 2 diabetes in 
the US is rising among those of all educational backgrounds, this increase is greatest in those 
who fail to graduate from high school [3]. This is presumed to be due to a less healthy lifestyle, 
in particular a higher prevalence of obesity and physical inactivity. In the general population, 
lower levels of education are also associated with an increased mortality and a greater risk of 
cardiovascular events [4]. The relationship between educational level and outcome in a large 
cohort of patients with type 2 diabetes, and the nature of any such association, has not been well 
described, although some evidence point out a possible association [5]. 
 
In general populations education is one of the most widely used markers of socioeconomic status 
and is inversely related to cardiovascular disease, cancer and death [6]. However, the 
mechanisms whereby a lower educational level is associated with an increased risk of 
cardiovascular death is not entirely clear. Several common cardiovascular risk factors tend to 
follow a socioeconomic gradient, risk factors being more prevalent [7] and unhealthy behaviour 
more common [8] with increasing social deprivation [9]. For all-cause mortality, alcohol-related 
deaths seem to cover the majority of the increased mortality in lower socioeconomic groups [10]. 
Additionally, geographical differences have been observed such that a lower educational 
attainment in Asia has been associated with a higher excess risk of cardiovascular disease and 
premature mortality than in the Western populations of Australasia [11]. 
 
The association between educational level and mortality has been well described whereas 
associations with major cardiovascular events and especially microvascular complications are 
poorly recognized in type 2 diabetes populations. The aims of this study are to assess whether, in 
individuals with type 2 diabetes, educational level is associated with vascular outcomes and 
mortality, whether the association varies with geographical region, and how much common 
cardiovascular risk markers and lifestyle factors explain the associations.   
 
 
2. Materials and methods 
The Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release 
Controlled Evaluation (ADVANCE) study (ClinicalTrials.gov number NCT00145925) was a 
factorial, randomized, controlled trial conducted in 20 countries which recruited 11,140 patients 
with type 2 diabetes [12]. Participants were eligible for the study if they were ≥55 years old, had 
been diagnosed with type 2 diabetes after the age of 30 years and had a minimum of one major 
macro or micro-vascular diabetic complication or at least one additional cardiovascular risk 
factor. The study made two randomized comparisons: a double-blind assessment of the efficacy 
of a fixed combination perindopril-indapamide (2mg/0.625mg for 3 months increasing, if 
tolerated, to 4mg/1.25mg) versus placebo, and an open-label evaluation of an intensive glucose 
lowering regimen using modified release gliclazide, with a target HbA1c of ≤6.5% (48 
mmol/mol), versus standard guideline based glycemic control. The study outcomes included all-
cause mortality, major cardiovascular events (defined as death from cardiovascular disease, non-
fatal stroke or non-fatal myocardial infarction) and microvascular events (defined as new or 
worsening renal disease or diabetic eye disease). All participants of the study provided written 
informed consent and approval was obtained from the local ethics committee in all participating 
centers. Detailed study eligibility criteria and study methods [12] as well as the main results [13, 
14], have been previously reported. 
 
The age of participants at the completion of their highest level of education was self-reported at 
baseline. Due to differences of schooling systems between the participant countries, education 
was included in the analyses as a dichotomized variable. Patients, who had completed their 
education before the age of 16, were considered to have a low level of education. Studied 
lifestyle variables included current smoking, physical activity by the number of sessions of 
activity of ≥15 minutes duration per week [15] and alcohol use (any regular alcohol consumption 
versus no alcohol consumption) [16]. Lipid lowering medication included any medication 
indicated for dyslipidemia. All medications for hypertension were recorded and beta-blockers 
were enquired separately. 
 
The effects of education level on outcomes in participants from different regions of the world 
were also examined using the following, pre-set geographic and economic partition: Asia (China, 
India, Malaysia, and the Philippines), eastern Europe (Czech Republic, Estonia, Hungary, 
Lithuania, Poland, Russia, and Slovakia), and established market economies (Australia, Canada, 
France, Germany, Ireland, Italy, The Netherlands, New Zealand, and the United Kingdom) [17]. 
2.1 Statistical analyses 
The associations between educational attainment and the study outcomes were explored first in 
Spearman correlation coefficients and thereafter in Cox proportional hazard models to assess the 
relationship in more detail.  The first model fitted included non-modifiable variables such as age, 
sex, ADVANCE study glycemic control arm, ADVANCE study blood pressure treatment arm 
and duration of diabetes and prior cardiovascular disease. Into the second model we added the 
modifiable risk factors of body-mass index, HbA1c, high-density lipoprotein cholesterol, low-
density lipoprotein cholesterol, triglycerides, creatinine clearance, systolic blood pressure, heart 
rate, blood pressure medication, lipid lowering medication and use of acetyl salicylic acid or 
thienopyridines. The final model assessed the impact of lifestyle factors and included all 
previous variables added with lifestyle factors of physical activity, smoking and alcohol use. To 
detect regional differences the final models for each outcome were tested in 3 geographic and 
economic partitions and tested for heterogeneity by fitting a model including regional interaction 




The age at completion of the highest level of education was available from all 11,140 
participants (table 1). The mean age at completion of the highest level of education was 18.4 
years and the median age was 17.0 years. Four thousand and twenty-four (36%) individuals had 
completed their highest level of education before the age of 16 years and formed the low 
education group. Individuals with lower educational attainment had lower levels of cholesterols, 
smoked less but had higher body mass index, systolic blood pressure and HbA1c, whereas no 
differences were observed in history of cardiovascular disease or in the duration of diabetes. 
Among cardiovascular medications, only lipid lowering medication differed between the groups 
and was higher in the group with lower educational attainment (Table 1).  
During a median of 5 years of follow up 1,147 (10%) participants experienced a major 
cardiovascular event, 1,136 (10%) experienced a microvascular complication and 1,031 (9%) 
patients died.  
3.1 Educational level and associations with outcomes 
In the first multivariable Cox proportional hazard analyses, with adjustment  for  the non-
modifiable variables, low education was associated with increased risk of major cardiovascular 
(hazard ratio (HR) 1.35, 95% CI 1.20-1.52, p<0.0001) and microvascular outcomes  (HR 1.26, 
95 % CI 1.12-1.42, p=0.0002 ) and all-cause mortality (HR 1.38, 95% CI 1.22-1.56, p<0.0001). 
In the second model with included modifiable risk markers apart from lifestyle variables, the 
corresponding numbers indicated similar risk for major cardiovascular (HR 1.31, 95% CI 1.16-
1.48, p<0.0001),  for microvascular outcomes (HR 1.23, 95 % CI 1.08-1.39, p=0.0013) and all-
cause mortality (HR 1.34, 95% CI 1.18-1.53, p<0.0001). Finally, comparable levels of 
associations were observed in the fully adjusted model included with lifestyle variables of 
smoking, physical activity and alcohol use (Figure 1).  
3.2 Geographic variation and analyses of heterogeneity  
The effects of educational attainment on outcomes varied across geographic and economic 
partition where associations between low levels of education and cardiovascular outcomes and 
all-cause mortality were strongest in East Europe and weakest in EMEs (Figure 2). All outcomes 
in the 3 different regions were tested for heterogeneity between educational level and region. For 
major cardiovascular events heterogeneity was found in EME (p=0.025) and in East Europe 
(p=0.0035) but not for Asia (p=0.97). For microvascular complications no heterogeneity was 
observed but instead for all-cause mortality heterogeneity was found in EME (p=0.013) and in 




The current study demonstrates that, among individuals with type 2 diabetes from an 
internationally representative trial, lower formal educational attainment is associated with a 
higher incidence of cardiovascular events and mortality. In addition, lower educational 
attainment is also associated with an increased risk of microvascular complications: a 
relationship that has been presumed but lacking robust confirmation.  
The associations between lower educational attainment and worse outcomes were consistent 
despite adjustment for a variety of non-modifiable as well as modifiable cardiovascular risk 
factors and lifestyle factors, suggesting that any effects of educational status are largely 
independent of these influences.  However, the extent of the observed risks appears to vary 
between geographic and economic regions such that the associations between educational 
attainment and outcome were less evident in EME and most apparent in East European countries. 
4.1 Education, cardiovascular and microvascular events and mortality 
The relationships between educational level and premature mortality and cardiovascular disease 
are well described in the general population, where individuals with a lower educational level are 
at increased risk of premature death [18] and cardiovascular disease is the major contributor to 
life-years lost [19]. Indeed, cardiovascular disease is reported to account for 35% of the life-
years lost before the age of 75 in persons who failed to complete high-school, whereas diabetes 
accounted for approximately 4% [19]. Nevertheless, there is a paucity of data relating to type 2 
diabetes and to our knowledge, no prior studies have reported the association between 
educational level and major cardiovascular and microvascular outcomes specifically in a large 
patient cohort with type 2 diabetes.   
Data on all-cause mortality based on follow up of over 2 million participants in the American 
Cancer Society cohorts from 1959–1972 and 1982–1996 confirmed a relationship between a 
lower level of educational attainment and increased death rates among those with diabetes, based 
on death certificate records [20]. The association between low educational level and the 
microvascular complications of type 2 diabetes is a novel finding. This is in keeping with other 
data from this cohort which demonstrate an association between microvascular complications 
and lifestyle factors, such as physical inactivity and moderate alcohol consumption [15, 16]. It 
seems likely that these associations are mediated through similar complex mechanisms to those 
that determine the relationship between educational level and major cardiovascular events and 
mortality. 
4.2 Regional differences  
In spite of widespread improvements in the treatment of cardiovascular disease and related risk 
factors such as diabetes, the incidence of cardiovascular complications differs significantly 
between geographical regions [21]. In addition, there are clear geographical differences in the 
prevalence of microvascular complications, even in newly diagnosed patients with diabetes. For 
example, the prevalence of retinopathy in newly diagnosed diabetes ranges from 1.5 % to 31% 
between different countries [22]. Potential explanations may include variation in the level of 
treatment [23] but it seems likely that the time between the onset of diabetes and diagnosis is 
also a factor.   
Although participation in the ADVANCE trial may partially mitigate any treatment related 
differences it is still likely that there will have been, pre-existing, geographical variations in the 
access to diagnostic services and medical care, especially to medications [23], and that these may 
play a role in reducing the impact of educational factors in higher income countries.   
4.3 Potential mechanisms 
The current results suggest that the mechanisms for the observed higher risk associated with 
lower educational level are not clearly mediated by current lifestyle or other cardiovascular risk 
factors. Nevertheless, there are reports associating lower levels of education with higher rates of 
smoking, higher body mass index, lower levels of physical activity and increased alcohol 
consumption [24]. Moreover, these may be accompanied with other, often inter-related, factors 
that may be important determinants of health outcomes; including lower income levels, poorer 
living conditions in childhood, consumption of a less healthy diet, higher prevalence of 
cardiovascular risk factors and psychosocial stressors [4]. A unifying determinant of all of these 
is socioeconomic status which is closely linked to educational attainment [6] and is associated 
with the prevalence of diabetes [25].  
 
Socioeconomic status may act independently of, or in combination, with lifestyle risk factors in 
influencing trajectories of health during life time [26, 27]. Three models have been proposed to 
explain how socioeconomic position may influence health. The latent effects model [28, 29] 
suggests low childhood socioeconomic position may provoke biological and behavioural changes 
that place individuals at higher risk, irrespective of their risk burden in adulthood, whereas in the 
pathway model [30] childhood conditions may trigger social circumstances and health behaviour 
affecting the risk trajectory. The third model, cumulative burden model, suggests the risk in 
adulthood is attributable to psychosocial, physiological and environmental factors not only in 
childhood but throughout life [30]. Based on our findings, the cumulative burden model would 
be the most likely of these to explain the disparity in risks, although it is presumably a mixture of 
all three.    
4.4 Strengths and limitations 
The current study is, as far as we are aware, the first to explore the relationship between 
educational level and outcomes in a large cohort of type 2 diabetes. Nonetheless, it has 
limitations. The age at the completion of highest level of education was recorded, but this is a 
crude indicator of educational attainment and we have no details regarding the schooling 
systems, which vary between the countries represented, or the receipt of informal education and 
training. The level of education is likely to influence the average income and social class of 
patients and this in turn may affect many other factors, including their access to healthcare. This 
is a potential confounding factor that we cannot assess. Similarly we can’t exclude the possibility 
that our adjustments don’t control the effects of the assessed lifestyle factors on the various risks, 
albeit done in best available detail, which could explain the observation at least in part. Finally, 
we acknowledge that the ADVANCE trial participants represent educational attainment gained 
mainly from 1950’s to 1970’s, with several socio-economic factors influencing on it, as well as 
the educational system itself have changed considerably since then. Therefore we can’t exclude a 
secular effect on the discovered associations. 
5. Conclusions 
 
This study shows that a higher level of education is associated with a reduced risk of major 
cardiovascular and microvascular complications and lower risk of all-cause mortality in patients 
with type 2 diabetes. These differences do not appear to be explained solely by lifestyle factors 
such as the level of physical activity, smoking and alcohol consumption. The effects of 
educational level on cardiovascular risk and mortality appear to be less important in high income 
countries.   
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 Table 1. Patient characteristics in general and by education groups   
 Total Low education  Higher 
education 
p 
No of individuals 11,140 4,024 7,116  
Age (years) 65.8 (6.4) 67.1 (6.3) 65.0 (6.3) <0.0001 
Female (%) 4.733(42.4) 2748 (49.3) 1985 (38.6) <0.0001 
Body mass index (kg/m2) 28.3 (5.2) 28.9 (5.4) 28.0 (5.0) <0.0001 
Current smoking (%) 1,550 (13.9) 491(12.2) 1,059(14.9) <0.0001 
Never smoked (%) 6,466 (58.0) 2,219 (55.1) 4,247 (59.7) <0.0001 
Alcohol use (%) 3,389 (30.4) 1,125 (30.2) 2,174 (30.6) <0.0001 
History of cardiovascular disease (%) 3,590 (32.2) 1,270 (31.6) 2,320 (32.6) 0.26 
History of microvascular disease (%) 1,155 (10.4) 475 (11.8) 680 (9.6) 0.0002 
History of stroke (%) 1,023 (9.2) 358 (8.9) 665 (9.3) 0.43 
Age at completion of highest level of 
education (years) 
18.4 (7.3) 12.9 (3.6) 21.5 (7.0) <0.0001 
Systolic blood pressure (mmHg) 145.0 (21.5) 146.4 (21.8) 144.2 (21.3) <0.0001 
Diastolic blood pressure (mmHg) 80.6 (10.9) 80.0 (10.9) 81.0 (11.0) <0.0001 
Heart rate (beats/minute) 74 (12) 74 (12) 74 (12) 0.20 
Total cholesterol  (mmol/l) 5.20 (1.19) 5.13 (1.17) 5.23 (1.20) <0.0001 
HDL-cholesterol (mmol/l) 1.26 (0.35) 1.25 (0.36) 1.26 (0.35) 0.033 
LDL-cholesterol (mmol/l) 3.11 (1.03) 3.06 (1.03) 3.14 (1.03) <0.0001 
Triglycerides (mmol/l) 1.95 (1.29) 1.95 (1.24) 1.96 (1.31) 0.40 
HbA1c (%) 7.51 (1.57) 7.60 (1.58) 7.47 (1.54) <0.0001 
Physical activity (times/week, 15 min. 
minimum/time) 
8.8 (10.8) 8.0 (8.9) 9.3 (11.7) <0.0001 
Creatinine clearance (ml/min) 82.3 (28.6) 79.9(29.7) 83.6(27.8) <0.0001 
ACE/ARB medication (%) 5,311 (47.7) 1,963 (48.8) 3,348 (47.0) 0.079 
Beta blocker (%) 2,729 (24.5) 930 (23.1) 1,799 (25.3) 0.011 
Any blood pressure medications (%) 8,365 (75.1) 3,043 (75.6) 5,322 (74.8) 0.33 
Lipid lowering medication (%) 3,934 (35.3) 1,519 (37.7) 2,415 (33.9) <0.0001 
Aspirin or thienopyridines (%)  5.199 (46.7) 1,868 (46.2) 3,331 (46.8) 0.69 
Duration of diabetes (years) 7.9 (6.4) 8.0 (6.5) 7.9 (6.3) 0.63 
Results shown as number (%) or mean (standard deviation). Completion of formal education before the 
age of 16 was categorized as a low level of education.  
Figure legends 
 
Figure 1. Hazard ratios for low education and outcomes.  
Footnote: Adjusted for age, sex, body mass index, glucose and blood pressure treatment arms, 
systolic blood pressure, heart rate, HbA1c, creatinine clearance, duration of diabetes, HDL-
cholesterol, LDL-cholesterol, triglycerides, lipid lowering medication, blood pressure 
medication, antithrombotic medication, history of cardiovascular disease, alcohol use, smoking, 
exercise and education.  
 
 
Figure 2. Education and outcomes by geographic and economic regions. 
Footnote: Asia = China, India, Malaysia, and the Philippines; Eastern Europe = The Czech 
Republic, Estonia, Hungary, Lithuania, Poland, Russia, and Slovakia; Established Market 
Economies = Australia, Canada, France, Germany, Ireland, Italy, The Netherlands, New 
Zealand, and the United Kingdom 
Adjustments as in figure 1.   
 
